文献速递肾移植

竞争与非竞争风险模型预测移植肾衰竭的对比研究

Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.
PubMed 文献 · J Am Soc Nephrol · 2024-10-16

该研究纳入10个国家11046例肾移植受者,开发长期移植肾衰竭预测模型,分别采用Cox、Fine-Gray和病因特异性Cox回归,不处理或处理带功能死亡竞争风险。结果显示两类模型预测性能相似,在高风险亚组中竞争风险模型校准度有改善趋势。

要点

  • 竞争与非竞争风险模型预测长期移植肾衰竭性能相似。
  • 高风险亚组(如供者年龄>65岁)竞争风险模型校准度有改善趋势。
  • 两种方法均可用于移植肾衰竭预测,需结合临床场景选择。

核心结论

  • 竞争风险与非竞争风险模型在预测长期移植肾衰竭方面表现相似。

研究设计与样本

  • 多国队列研究,纳入10个国家11046例肾移植受者,开发预测模型并进行外部验证。
  • 使用Cox、Fine-Gray和病因特异性Cox回归,比较不处理与处理带功能死亡竞争风险的模型。
  • 中位风险评价后随访4.7年(四分位距2.7–7.0),1497例(14%)移植肾失功,1003例(9%)带功能死亡。

主要发现

  • 移植肾失功累积发生率Kaplan-Meier与Aalen-Johansen法估计相似(推导队列17% vs 16%)。
  • Cox、Fine-Gray和病因特异性Cox模型平均绝对预测误差分别为0.0140、0.0138和0.0135。
  • 验证队列中一致性指数范围为0.76至0.87,区分度和整体拟合相似。
  • 部分高风险组(如供者年龄>65岁)竞争风险模型校准度有中度改善趋势。

临床怎么用

  • 长期移植肾衰竭预测可选用竞争或非竞争风险模型,两者性能相当。
  • 在高风险亚组中可考虑竞争风险模型以可能改善校准度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prognostic models are becoming increasingly relevant in clinical trials as potential surrogate end points and for patient management as clinical decision support tools. However, the effect of competing risks on model performance remains poorly investigated. We aimed to carefully assess the performance of competing risk and noncompeting risk models in the context of kidney transplantation, where allograft failure and death with a functioning graft are two competing outcomes. METHODS: We included 11,046 kidney transplant recipients enrolled in ten countries. We developed prediction models for long-term kidney graft failure prediction, without accounting (i.e., censoring) and accounting for the competing risk of death with a functioning graft, using Cox, Fine–Gray, and cause-specific Cox regression models. To this aim, we followed a detailed and transparent analytical framework for competing and noncompeting risk modeling and carefully assessed the models' development, stability, discrimination, calibration, overall fit, clinical utility, and generalizability in external validation cohorts and subpopulations. More than 15 metrics were used to provide an exhaustive assessment of model performance. RESULTS: Among 11,046 recipients in the derivation and validation cohorts, 1497 (14%) lost their graft and 1003 (9%) died with a functioning graft after a median follow-up postrisk evaluation of 4.7 years (interquartile range, 2.7–7.0). The cumulative incidence of graft loss was similarly estimated by Kaplan–Meier and Aalen–Johansen methods (17% versus 16% in the derivation cohort). Cox and competing risk models showed similar and stable risk estimates for predicting long-term graft failure (average mean absolute prediction error of 0.0140, 0.0138, and 0.0135 for Cox, Fine–Gray, and cause-specific Cox models, respectively). Discrimination and overall fit were comparable in the validation cohorts, with concordance index ranging from 0.76 to 0.87. Across various subpopulations and clinical scenarios, the models performed well and similarly, although in some high-risk groups (such as donors older than 65 years), the findings suggest a trend toward moderately improved calibration when using a competing risk approach. CONCLUSIONS: Competing and noncompeting risk models performed similarly in predicting long-term kidney graft failure.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Truchot A, Raynaud M, Helanterä I, et al. Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure. J Am Soc Nephrol. 2024. PMID: 40168162. doi:10.1681/ASN.0000000517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。